2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide

C26H31Cl2N5O — CID 139414605

IUPAC2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide
SMILESCCc1cnc(-c2cc(NC(=O)c3ccc(N4C[C@@H](C)N(CC)[C@H](C)C4)cc3Cl)ccc2Cl)[nH]1
InChIInChI=1S/C26H31Cl2N5O/c1-5-18-13-29-25(30-18)22-11-19(7-10-23(22)27)31-26(34)21-9-8-20(12-24(21)28)32-14-16(3)33(6-2)17(4)15-32/h7-13,16-17H,5-6,14-15H2,1-4H3,(H,29,30)(H,31,34)/t16-,17-/m1/s1
InChIKeyFMMOPHSMVNOSNX-IAGOWNOFSA-N
MW500.47 g/mol
LogP6.12
Rot. Bonds6

About 2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide

2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide (PubChem CID 139414605) has the molecular formula C26H31Cl2N5O and a molecular weight of 500.47 g/mol. Its IUPAC name is 2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide.

Molecular Properties

Compound Name2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide
PubChem CID139414605
Molecular FormulaC26H31Cl2N5O
Molecular Weight500.47 g/mol
Exact Mass499.19
IUPAC Name2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide
SMILESCCc1cnc(-c2cc(NC(=O)c3ccc(N4C[C@@H](C)N(CC)[C@H](C)C4)cc3Cl)ccc2Cl)[nH]1
InChIInChI=1S/C26H31Cl2N5O/c1-5-18-13-29-25(30-18)22-11-19(7-10-23(22)27)31-26(34)21-9-8-20(12-24(21)28)32-14-16(3)33(6-2)17(4)15-32/h7-13,16-17H,5-6,14-15H2,1-4H3,(H,29,30)(H,31,34)/t16-,17-/m1/s1
InChIKeyFMMOPHSMVNOSNX-IAGOWNOFSA-N
XLogP6.12
TPSA64.26 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms34
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500500.47
LogP ≤ 56.12
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze 2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide?
The IUPAC name of 2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide (CID 139414605) is 2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide.
What is the SMILES notation for 2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide?
The canonical SMILES for 2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide is CCc1cnc(-c2cc(NC(=O)c3ccc(N4C[C@@H](C)N(CC)[C@H](C)C4)cc3Cl)ccc2Cl)[nH]1.
What is the InChIKey of 2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide?
The InChIKey is FMMOPHSMVNOSNX-IAGOWNOFSA-N. The full InChI is InChI=1S/C26H31Cl2N5O/c1-5-18-13-29-25(30-18)22-11-19(7-10-23(22)27)31-26(34)21-9-8-20(12-24(21)28)32-14-16(3)33(6-2)17(4)15-32/h7-13,16-17H,5-6,14-15H2,1-4H3,(H,29,30)(H,31,34)/t16-,17-/m1/s1.
What are the key properties of 2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide?
2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide has a molecular weight of 500.47 g/mol, XLogP of 6.12, 6 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-chloro-N-[4-chloro-3-(5-ethyl-1H-imidazol-2-yl)phenyl]-4-[(3R,5R)-4-ethyl-3,5-dimethylpiperazin-1-yl]benzamide is sourced from PubChem (CID 139414605), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).